Panretin (Pan-RET-in, alitretinoin) gel, the first TOPICAL treatment for Kaposi's sarcoma

The FDA just approved Panretin (Pan-RET-in, alitretinoin) gel, the first TOPICAL treatment for Kaposi's sarcoma.

Alitretinoin is a form of retinoic acid.

It's applied to skin lesions to inhibit cell growth...it doesn't prevent new lesions or treat systemic disease.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote